Abstract 78: Snord67 promotes breast cancer metastasis through U6-mediated alternative splicing
Authors: Katherine Ismei Zhou, Yvonne L. Chao, Kwame K. Forbes, Alessandro Porrello, Gabrielle M. Gentile, Yinzhou Zhu, Aaron C. Chack, Dixcy J. John Mary, Haizhou Liu, Eric Cockman, Lincy Edatt, Grant A. Goda, Justin Zhao, Hala A. Assi, Hannah J. Wiedner, Yi-Hsuan Tsai, Lily Wilkinson, Amanda E. Van Swearingen, Lisa A. Carey, Jimena Giudice, Daniel Dominguez, Christopher L. Holley, Chad V. Pecot
Journal: Cancer Research (2025)

Abstract Small nucleolar RNAs (snoRNAs) are a class of ncRNAs that canonically guide post-transcriptional modifications, including 2'-O-methylation, on ribosomal RNA (rRNA) and small nuclear RNA (snRNA). While traditionally considered housekeeping genes, snoRNAs have increasingly been found to function in diverse physiologic and pathologic processes, including cancer. In an immune-competent murine model of triple negative breast cancer (TNBC) lymphatic metastasis, we identified the snoRNA Snord67 as one of the most upregulated noncoding RNAs in axillary LN (AxLN) tumors relative to mammary fat pad (MFP) tumors and lung metastases. Loss of Snord67 resulted in decreased colony formation and spheroid size in murine and human TNBC cell lines, and led to decreased lymph node tumor growth and decreased distant metastases in two immune-competent murine models of TNBC lymphatic dissemination. To determine the mechanism by which Snord67 promotes tumor growth and metastasis, we examined the impact of Snord67 on 2'-O-methylation, gene expression, and alternative splicing. Loss of Snord67 in TNBC cell lines led to decreased 2'-O-methylation at the C60 nucleotide (Cm60) in the core spliceosome component U6 snRNA. Re-introduction of wild-type Snord67 rescued Cm60 in U6 snRNA and rescued the colony formation and spheroid phenotypes of the Snord67 knockout cell lines. However, a mutant Snord67 incapable of guiding U6 Cm60 only partially rescued these in vitro phenotypes, suggesting that Snord67 promotes in vitro tumor cell growth at least in part by guiding Cm60 in U6 snRNA. We then performed RNA sequencing of Snord67 knockout and wild-type murine and human TNBC cell lines. We found that loss of Snord67 led to widespread changes in alternative splicing, consistent with its role in guiding 2'-O-methylation of the core spliceosome component U6. We further demonstrated that the inclusion of alternatively spliced cassette exons in MYO18A and NFYA was not only downregulated upon Snord67 knockout in a human TNBC cell line, but also positively correlated with Snord67 expression levels in primary breast tumors and lymph node metastases from breast cancer patients. Based on these results, we propose a model in which Snord67 guides U6 Cm60, which leads to a pro-metastatic alternative splicing program and thereby promotes lymph node tumor growth and distant metastasis. Citation Format: Katherine Ismei Zhou, Yvonne L. Chao, Kwame K. Forbes, Alessandro Porrello, Gabrielle M. Gentile, Yinzhou Zhu, Aaron C. Chack, Dixcy J. John Mary, Haizhou Liu, Eric Cockman, Lincy Edatt, Grant A. Goda, Justin Zhao, Hala A. Assi, Hannah J. Wiedner, Yi-Hsuan Tsai, Lily Wilkinson, Amanda E. Van Swearingen, Lisa A. Carey, Jimena Giudice, Daniel Dominguez, Christopher L. Holley, Chad V. Pecot. Snord67 promotes breast cancer metastasis through U6-mediated alternative splicing [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 78.